SUS — Surgical Science Sweden AB Income Statement
0.000.00%
Last trade - 00:00
- SEK6.19bn
- SEK5.53bn
- SEK882.85m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 102 | 105 | 367 | 803 | 883 |
Cost of Revenue | |||||
Gross Profit | 83.6 | 88.4 | 266 | 532 | 613 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 86.3 | 84.8 | 310 | 640 | 694 |
Operating Profit | 15.2 | 20 | 56.5 | 163 | 189 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.2 | 19.7 | 65.8 | 208 | 268 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.6 | 15.6 | 86.2 | 188 | 234 |
Net Income Before Extraordinary Items | |||||
Net Income | 12.6 | 15.6 | 86.2 | 188 | 234 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.6 | 15.6 | 86.2 | 188 | 234 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.434 | 0.433 | 2.02 | 3.69 | 4.59 |
Dividends per Share |